Robinhood CEO says issuers should not have veto over tokenized stocks

A Question of Who Gets to Say No

Robinhood CEO Vlad Tenev has staked out a clear position on one of the more contentious design questions in the tokenized securities space: corporate issuers should not hold veto power over tokenized stock instruments, at least not when those instruments are structured as separate products backed by underlying shares rather than direct representations of equity ownership.

The distinction Tenev is drawing is not cosmetic.

When a tokenized product changes what shareholders are actually entitled to – altering voting rights, dividend mechanics, or the legal obligations a company carries toward its investors – issuer involvement makes sense. That is a structural change to the equity relationship itself, and companies have a legitimate stake in how their ownership layer is modified. But when a financial product is constructed as a separate instrument that happens to be collateralized by shares, Tenev’s argument is that the issuer’s role ends at the share level, not at the product level built on top of it.

Where the Tokenized Equity Debate Actually Lives

The tokenization of traditional securities has moved from theoretical whitepaper territory into active product development at several major financial platforms. The fundamental tension in this space is not really about blockchain infrastructure – it is about who controls the financial and legal architecture sitting on top of that infrastructure. Tokenized stock products can be engineered in meaningfully different ways: some replicate the full legal ownership experience of holding a share, while others function more like synthetic exposure vehicles that track share performance without conferring direct equity rights.

Tenev’s position targets the second category. If a platform issues a token that tracks Apple or Tesla stock but is legally structured as a separate instrument – collateralized by actual shares held in custody – the issuing company in that scenario is Apple or Tesla, not the token’s sponsor. Under that structure, Apple’s executives have no more claim to review or block that token product than they would have over a derivative or an ETF that references their stock. The product is not Apple’s equity; it is a financial instrument that happens to reference Apple’s equity.

This framing has direct implications for how platforms like Robinhood could build and distribute tokenized stock products, particularly in markets outside the United States where regulatory pathways for such instruments are more developed. Giving corporate issuers approval rights over third-party financial products that merely reference their shares would create a veto structure that has no clear precedent in traditional derivatives or fund markets – and would effectively let companies control how their stock gets packaged and sold on secondary financial rails they did not build.

What Issuer Involvement Should Actually Look Like

Tenev is not arguing for zero issuer involvement across the board. H is position is conditional and structural. Where tokenized products genuinely alter the relationship between a company and its shareholders – changing how votes are cast, how dividends flow, or how corporate obligations are defined – issuers have a defensible reason to be at the table. Those are not peripheral product decisions. They touch the core of what equity ownership means and what companies are legally required to do for the people who hold their stock.

The line Tenev is drawing sits between that category and the category of instruments that are financially linked to shares but legally separate from them. A token that pays a return correlated to a stock’s price movement, backed by shares held in a custodial account, does not renegotiate the relationship between the company and its shareholders. It creates a new financial relationship between a token issuer and a token buyer, one that runs parallel to the equity market rather than inside it.

Whether regulators – particularly in the U.S., where the SEC has not issued clear guidance on tokenized equity structures – will accept that boundary is an open question. The same functional distinction that Tenev finds obvious could be contested by an issuer that argues any tokenized product bearing its company’s name and economic exposure requires their sign-off. Legal frameworks around synthetic equity exposure, even in traditional markets, are not uniformly settled across jurisdictions.

The Stakes for Platforms Building in This Space

Robinhood has been expanding its product footprint in Europe, where tokenized asset frameworks have progressed further than in the United States. The practical relevance of Tenev’s position is therefore not abstract – it shapes what kind of products Robinhood and its competitors can bring to market without negotiating individual permissions from every company whose stock they want to reference. A regime where issuers hold approval rights over tokenized instruments referencing their shares would impose a friction cost that scales with the number of tickers a platform wants to support, potentially concentrating that market around issuers willing to participate in formal agreements while excluding the rest.

That is not a hypothetical concern. It is the structural outcome of applying issuer-consent logic to reference-based financial products, and it is the specific outcome Tenev appears to be arguing against.

The more pointed question is what happens when a company actively objects – not because a tokenized product changes shareholder rights, but because it does not want its stock being traded in a form it does not control. Nothing in Tenev’s framework, as stated, addresses whether that objection has any legal traction, or whether the answer simply depends on which jurisdiction the platform is operating in when it issues the token.